Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Are Currently Being Treated With Eculizumab Active Not Recruiting Phase 3 Trials for Ravulizumab (DB11580)

IndicationStatusPhase
DBCOND0082768 (Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Are Currently Being Treated With Eculizumab)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03056040ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With EculizumabTreatment